13F Holdings
中文EN

MTD METTLER TOLEDO INTERNATIONAL INC/

Laboratory Analytical Instruments · NYSE · SEC CIK 1037646 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2025Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.5%
TTM net income YoY11.8%
TTM EPS YoY15.0%
Revenue 3-yr CAGR2.4%
Net income 3-yr CAGR5.6%

Margins

Gross margin60.4%
Operating margin—
Net margin22.2%
FCF margin20.7%
EBITDA margin—

Returns

ROE—
ROA25.9%
ROIC (approx.)—
Asset turnover1.16x

Leverage & solvency

Liabilities / assets97.9%
Debt / equity26.06x
Current ratio1.10x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.05x
Accruals ratio-1.4%
Payout ratio—
Capex / revenue2.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$4.03B$3.87B$3.79B$3.92B$3.72B
Gross profit$2.39B$2.33B$2.24B$2.31B$2.17B
R&D expense$199.37M$189.36M$185.28M$177.12M$169.77M
SG&A expense$998.31M$936.30M$904.11M$938.46M$943.98M
Interest expense$68.52M$74.63M$77.37M$55.39M$43.24M
Pretax income$1.05B$1.04B$973.73M$1.07B$949.36M
Income tax$179.72M$174.08M$184.95M$198.09M$180.38M
Net income$869.19M$863.14M$788.78M$872.50M$768.99M
EPS (basic)42.1740.6736.1038.7933.25
EPS (diluted)42.0540.4835.9038.4132.78
Weighted avg. shares (diluted)20.67M21.32M21.97M22.72M23.46M
Balance sheet
Cash & equivalents$66.89M$59.36M$69.81M$95.97M$98.56M
Receivables$778.24M$687.11M$663.89M$709.32M$647.34M
Inventory$387.23M$342.27M$385.87M$441.69M$414.54M
Current assets$1.36B$1.19B$1.23B$1.38B$1.27B
PP&E, net$845.64M$770.28M$803.37M$778.60M$799.37M
Goodwill$739.23M$668.91M$670.11M$660.17M$648.62M
Intangibles$278.91M$257.14M$285.43M$306.05M$307.45M
Total assets$3.71B$3.24B$3.36B$3.49B$3.33B
Current liabilities$1.20B$1.17B$1.18B$1.15B$1.15B
Short-term debt$63.93M$182.62M$192.22M$106.05M$101.13M
Long-term debt$2.09B$1.83B$1.89B$1.91B$1.58B
Total debt$2.15B$2.01B$2.08B$2.01B$1.68B
Total liabilities$3.74B$3.37B$3.51B$3.47B$3.16B
Shareholders' equity-$23.64M-$126.89M-$149.94M$24.79M$171.42M
Net debt$2.09B$1.95B$2.01B$1.92B$1.58B
Shares outstanding22.14M20.95M21.53M22.14M22.84M
Cash flow statement
Operating cash flow$955.77M$968.35M$965.87M$859.07M$908.83M
Capital expenditure$107.12M$103.90M$105.32M$121.24M$107.58M
Free cash flow$848.65M$864.45M$860.55M$737.83M$801.25M
Investing cash flow-$193.87M-$119.46M-$131.69M-$139.40M-$314.11M
Financing cash flow-$755.17M-$855.98M-$859.59M-$716.04M-$590.55M
Depreciation & amortization$51.14M$50.35M$48.95M$46.78M$44.98M
Stock-based compensation$22.51M$19.98M$17.93M$19.66M$19.59M
Share buybacks$800.00M$850.00M$900.00M$1.10B$1,000.00M

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.